المؤلفون: Lyu R; Bioinformatics and Cellular Genomics, St. Vincent's Institute of Medical Research, Melbourne, Australia.; Melbourne Integrative Genomics, Faculty of Science, The University of Melbourne, Melbourne, Australia., Tsui V; DNA Repair and Recombination Laboratory, St. Vincent's Institute of Medical Research, Melbourne, Australia.; The Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, Australia., McCarthy DJ; Bioinformatics and Cellular Genomics, St. Vincent's Institute of Medical Research, Melbourne, Australia. dmccarthy@svi.edu.au.; Melbourne Integrative Genomics, Faculty of Science, The University of Melbourne, Melbourne, Australia. dmccarthy@svi.edu.au., Crismani W; DNA Repair and Recombination Laboratory, St. Vincent's Institute of Medical Research, Melbourne, Australia. wcrismani@svi.edu.au.; The Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, Australia. wcrismani@svi.edu.au.

المصدر: Genome biology [Genome Biol] 2021 Apr 19; Vol. 22 (1), pp. 112. Date of Electronic Publication: 2021 Apr 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

مواضيع طبية MeSH: Genome* , High-Throughput Nucleotide Sequencing*/methods, Genomics/*methods , Germ Cells/*metabolism , Precision Medicine/*methods , Single-Cell Analysis/*methods, Animals ; Chromosome Mapping ; Computational Biology/methods ; Computational Biology/standards ; Data Interpretation, Statistical ; Genetic Heterogeneity ; Genomics/standards ; Humans ; Precision Medicine/standards ; Reproducibility of Results ; Sensitivity and Specificity ; Single-Cell Analysis/standards ; Whole Genome Sequencing

المؤلفون: Logsdon GA; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA., Vollger MR; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA., Eichler EE; Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA. eee@gs.washington.edu.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA. eee@gs.washington.edu.

المصدر: Nature reviews. Genetics [Nat Rev Genet] 2020 Oct; Vol. 21 (10), pp. 597-614. Date of Electronic Publication: 2020 Jun 05.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100962779 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0064 (Electronic) Linking ISSN: 14710056 NLM ISO Abbreviation: Nat Rev Genet Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Genetic Variation* , Genome, Human* , Precision Medicine*, Disease/*genetics , Genomics/*methods , High-Throughput Nucleotide Sequencing/*methods, Chromosome Mapping ; Humans

المؤلفون: Aimono E; Division of Clinical Cancer Genomics, Keio University School of Medicine., Nishihara H; Division of Clinical Cancer Genomics, Keio University School of Medicine.

المصدر: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2020; Vol. 140 (5), pp. 651-655.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Nihon Yakugakkai Country of Publication: Japan NLM ID: 0413613 Publication Model: Print Cited Medium: Internet ISSN: 1347-5231 (Electronic) Linking ISSN: 00316903 NLM ISO Abbreviation: Yakugaku Zasshi Subsets: MEDLINE

مواضيع طبية MeSH: Genome, Human* , Genomics* , Patient Care Team* , Pharmacists* , Precision Medicine*, Genetic Testing/*methods , Genetic Therapy/*methods , High-Throughput Nucleotide Sequencing/*methods , Neoplasms/*genetics, Humans ; Neoplasms/diagnosis ; Neoplasms/drug therapy ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use

المؤلفون: Bertucci F; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France. bertuccif@ipc.unicancer.fr.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. bertuccif@ipc.unicancer.fr., Gonçalves A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Guille A; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Adelaïde J; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Garnier S; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Carbuccia N; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Billon E; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Finetti P; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Sfumato P; Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France., Monneur A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Pécheux C; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France., Khran M; Department of Medical genetics, Hôpital Timone Enfants, AP-HM, Marseille, France.; Aix-Marseille University, Inserm, U1251-MMG, Marseille Medical Genetics, Marseille, France., Brunelle S; Department of Imaging, Institut Paoli-Calmettes, Marseille, France., Mescam L; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Thomassin-Piana J; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Poizat F; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Charafe-Jauffret E; Department of Biopathology, Institut Paoli-Calmettes, Marseille, France., Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France., Lambaudie E; Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France., Provansal M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Extra JM; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Madroszyk A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Sabatier R; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Mamessier E; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Chabannon C; Biobank, Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Pakradouni J; Department of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France., Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., André F; Department of Medical Oncology, Gustave Roussy Cancer Campus, UMR981 Inserm, Villejuif, France.; Paris Sud University, Orsay, France., Gravis G; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Popovici C; Department of Oncogenetics, Institut Paoli-Calmettes, Marseille, France., Birnbaum D; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France., Chaffanet M; Laboratory of Predictive Oncology, Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University, 232 Boulevard Sainte-Marguerite, 13009, Marseille, France.

المصدر: Genome medicine [Genome Med] 2021 May 18; Vol. 13 (1), pp. 87. Date of Electronic Publication: 2021 May 18.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor* , Genomics*/methods , High-Throughput Nucleotide Sequencing*, Neoplasms/*diagnosis , Neoplasms/*genetics, Adult ; Aged ; Aged, 80 and over ; Biopsy ; Combined Modality Therapy ; Comparative Genomic Hybridization ; Disease Management ; Disease Susceptibility ; Female ; Genetic Variation ; Humans ; Male ; Middle Aged ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms/mortality ; Neoplasms/therapy ; Precision Medicine/methods ; Prognosis ; Prospective Studies ; Treatment Outcome ; Young Adult

المؤلفون: Leguia M; Laboratorio de Genómica, Pontificia Universidad Católica del Perú, Lima., Vila-Sanjurjo A; Departamento de Bioloxía Celular e Molecular, Facultade de Ciencias, Universidade de A Coruña, Spain., Chain PSG; Bioscience Division, Los Alamos National Laboratory, New Mexico., Berry IM; Walter Reed Army Institute of Research, Silver Spring, Maryland., Jarman RG; Walter Reed Army Institute of Research, Silver Spring, Maryland., Pollett S; Walter Reed Army Institute of Research, Silver Spring, Maryland.; Department of Preventive Medicine and Biostatistics (Uniformed Services University of the Health Sciences), Bethesda, Maryland.

المصدر: The Journal of infectious diseases [J Infect Dis] 2020 Mar 28; Vol. 221 (Suppl 3), pp. S289-S291.

نوع المنشور: Introductory Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Genomics* , High-Throughput Nucleotide Sequencing* , Precision Medicine* , Public Health*, Communicable Diseases/*microbiology, Communicable Diseases/parasitology ; Communicable Diseases/virology ; Humans

المؤلفون: Morganti S; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Tarantino P; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Ferraro E; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., D'Amico P; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Viale G; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Trapani D; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Duso BA; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapy, IEO, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@unimi.it.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2019 Jan; Vol. 133, pp. 171-182. Date of Electronic Publication: 2018 Nov 26.

نوع المنشور: Historical Article; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Data Interpretation, Statistical* , Genomics*/history , Genomics*/methods , Genomics*/standards , High-Throughput Nucleotide Sequencing*/history , High-Throughput Nucleotide Sequencing*/standards , High-Throughput Nucleotide Sequencing*/statistics & numerical data , Precision Medicine*/history , Precision Medicine*/methods , Precision Medicine*/standards, Neoplasms/*genetics , Neoplasms/*therapy, Diagnostic Tests, Routine/history ; Diagnostic Tests, Routine/methods ; Diagnostic Tests, Routine/statistics & numerical data ; Disease Progression ; History, 20th Century ; History, 21st Century ; Humans ; Mutation ; Neoplasms/diagnosis ; Research Design/standards

المؤلفون: Matthews AM; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada., Blydt-Hansen I; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Al-Jabri B; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.; Department of Pediatrics, King Abdul Aziz University, Jeddah, Saudi Arabia., Andersen J; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.; Department of Physical Medicine & Rehabilitation, University of Alberta, Edmonton, AB, Canada., Tarailo-Graovac M; Departments of Biochemistry, Molecular Biology, and Medical Genetics, Cumming School of Medicine, Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada., Price M; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada., Selby K; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Demos M; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Connolly M; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Drögemoller B; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Shyr C; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Mwenifumbo J; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Elliott AM; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Lee J; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Ghani A; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Stöckler S; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Salvarinova R; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Vallance H; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada.; Department of Pathology and Laboratory medicine, University of British Columbia, Vancouver, BC, Canada., Sinclair G; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory medicine, University of British Columbia, Vancouver, BC, Canada., Ross CJ; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Wasserman WW; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada., McKinnon ML; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.; BC Children's Hospital Research Institute, Vancouver, BC, Canada., Horvath GA; BC Children's Hospital Research Institute, Vancouver, BC, Canada.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada., Goez H; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada., van Karnebeek CD; BC Children's Hospital Research Institute, Vancouver, BC, Canada. c.d.vankarnebeek@amc.uva.nl.; Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. c.d.vankarnebeek@amc.uva.nl.; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada. c.d.vankarnebeek@amc.uva.nl.; Departments of Pediatrics and Clinical Genetics, Amsterdam University Medical Centres, Amsterdam, The Netherlands. c.d.vankarnebeek@amc.uva.nl.

مؤلفون مشاركون: TIDE BC, United for Metabolic Diseases and the CAUSES Study

المصدر: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2019 Jul; Vol. 21 (7), pp. 1621-1628. Date of Electronic Publication: 2018 Dec 13.

نوع المنشور: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE

مواضيع طبية MeSH: Genomics* , High-Throughput Nucleotide Sequencing* , Precision Medicine*, Cerebral Palsy/*diagnosis, Adult ; Cerebral Palsy/genetics ; Child ; Female ; Genetic Association Studies ; Humans ; Male ; Molecular Diagnostic Techniques

المؤلفون: Takeuchi S; Division of Cancer Genome Informatics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan.; Division of Bioinformatics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan., Okuda S; Division of Cancer Genome Informatics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan. okd@med.niigata-u.ac.jp.; Division of Bioinformatics, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, 951-8510, Japan. okd@med.niigata-u.ac.jp.

المصدر: International journal of clinical oncology [Int J Clin Oncol] 2019 Feb; Vol. 24 (2), pp. 123-130. Date of Electronic Publication: 2018 Dec 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Knowledge Bases* , Mutation* , Precision Medicine*, Biomarkers, Tumor/*genetics , Genomics/*methods , High-Throughput Nucleotide Sequencing/*methods , Neoplasms/*genetics, Humans ; Japan ; Neoplasms/diagnosis ; Neoplasms/therapy

المؤلفون: Slevin MK; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wollison BM; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Powers W; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Burns RT; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Patel N; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ducar MD; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Starrett GJ; Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Garcia EP; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Manning DK; Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Cheng J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kaye KM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Van Hummelen P; Division of Oncology, Department of Medicine, Genome Technology Center, Stanford University, Stanford, California., Nag A; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Thorner AR; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., MacConaill LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: laura_macconaill@dfci.harvard.edu.

المصدر: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2020 Apr; Vol. 22 (4), pp. 476-487. Date of Electronic Publication: 2020 Feb 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE

مواضيع طبية MeSH: Genome, Human* , Genomics*/methods , Genomics*/standards , High-Throughput Nucleotide Sequencing*/methods, Neoplasms/*diagnosis , Neoplasms/*etiology , Tumor Virus Infections/*complications , Tumor Virus Infections/*virology, Cell Transformation, Viral ; Computational Biology/methods ; Genome, Viral ; Genotype ; Humans ; Phylogeny ; Polymorphism, Single Nucleotide ; Precision Medicine/methods ; Sensitivity and Specificity ; Tumor Virus Infections/diagnosis ; Virus Integration

المؤلفون: Ziogas DE; a Centre for Biosystems and Genome Network Medicine , Ioannina University , Ioannina , Greece.; d Department of Surgery , 'G. Hatzikosta' General Hospital , Ioannina , Greece., Kyrochristos ID; a Centre for Biosystems and Genome Network Medicine , Ioannina University , Ioannina , Greece.; b Department of Surgery , Ioannina University Hospital , Ioannina , Greece., Roukos DH; a Centre for Biosystems and Genome Network Medicine , Ioannina University , Ioannina , Greece.; b Department of Surgery , Ioannina University Hospital , Ioannina , Greece.; c Department of Systems Biology , Biomedical Research Foundation of the Academy of Athens (BRFAA) , Athens , Greece.

المصدر: Expert review of medical devices [Expert Rev Med Devices] 2018 Jan; Vol. 15 (1), pp. 1-3. Date of Electronic Publication: 2017 Dec 28.

نوع المنشور: Editorial; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101230445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-2422 (Electronic) Linking ISSN: 17434440 NLM ISO Abbreviation: Expert Rev Med Devices Subsets: MEDLINE

مواضيع طبية MeSH: Genomics* , High-Throughput Nucleotide Sequencing* , Medical Oncology* , Precision Medicine*, Genome ; Humans ; Neoplasms/genetics ; Neoplasms/therapy